Parbeen Singh
- Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery 7
- Drug Solubulity and Delivery Systems 3
- Dermatology top 5%
- Dermatology and Skin Diseases 2
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 4
- Molecular Medicine top 10%
-
- Nanoplatforms for cancer theranostics 3
-
- Lipid Membrane Structure and Behavior 3
-
- Electrohydrodynamics and Fluid Dynamics 2
-
- Proteoglycans and glycosaminoglycans research 2
- Journals
- International Journal of Pharmaceutics (4 papers)Journal of Pharmaceutical and Biomedical Analysis (2 papers)Journal of Controlled Release (2 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Parbeen Singh
17 papers receiving 567 citations
Peers
Comparison fields: 5 of 85
- Pharmaceutical Science 328
- Dermatology 127
- Biomaterials 133
- Molecular Medicine 35
- Biomedical Engineering 148
Countries citing papers authored by Parbeen Singh
This map shows the geographic impact of Parbeen Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parbeen Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parbeen Singh more than expected).
Fields of papers citing papers by Parbeen Singh
This network shows the impact of papers produced by Parbeen Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parbeen Singh. The network helps show where Parbeen Singh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Parbeen Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 20 | |
| 4 | 2024 | 9 | |
| 5 | 2022 | 23 | |
| 6 | 2022 | 33 | |
| 7 | 2022 | 20 | |
| 8 | 2021 | 25 | |
| 9 | 2021 | 44 | |
| 10 | 2020 | 4 | |
| 11 | 2020 | 27 | |
| 12 | 2019 | 178 | |
| 13 | 2019 | 92 | |
| 14 | 2018 | 57 | |
| 15 | 2017 | 18 | |
| 16 | 2016 | 5 | |
| 17 | 2016 | 5 |
About Parbeen Singh
Parbeen Singh is a scholar working on Pharmaceutical Science, Biomaterials, Dermatology, Molecular Medicine and Cell Biology, having authored 17 papers that have together received 570 indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (7 papers), Nanoparticle-Based Drug Delivery (4 papers), Drug Solubulity and Delivery Systems (3 papers), Lipid Membrane Structure and Behavior (3 papers), Nanoplatforms for cancer theranostics (3 papers), Electrohydrodynamics and Fluid Dynamics (2 papers), Dermatology and Skin Diseases (2 papers) and Proteoglycans and glycosaminoglycans research (2 papers). The work is most often cited by research in Pharmaceutical Science (328 citations), Dermatology (127 citations), Biomaterials (133 citations), Molecular Medicine (35 citations) and Biomedical Engineering (148 citations). Parbeen Singh has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Xu Zhang, Andrew Carrier, Shufen Cui, Yongli Chen, Jinlin Wang, Ken D. Oakes, Yikun Yang, Xiaohong Ren, Li Wu and Tiangang Luan. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical and Biomedical Analysis, Journal of Controlled Release, ACS Applied Materials & Interfaces and Drug Delivery and Translational Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.